Novo Holdings participates in EUR110m first closing of Sound Bioventures Fund I
Novo Holdings, an international life sciences investor, today announced that it has invested in Sound Bioventures Fund I as cornerstone investor in the first close of EUR110 million. Sound Bioventures will be investing in private biotech companies and will focus on companies with assets in clinical or late pre-clinical stages,